Sphera Funds Management’s Array Biopharma Inc ARRY Stock Holding History

Sphera Funds Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-125,000	Closed	-$1.78M	–	136
2018 Q4	$1.78M	Sell	125,000 -270,000	-68%	-$4.1M	0.2%	79
2018 Q3	$6M	Buy	395,000 +55,196	+16%	+$846K	0.69%	37
2018 Q2	$5.7M	Sell	339,804 -65,196	-16%	-$1.04M	0.79%	34
2018 Q1	$6.61M	Hold	405,000	–	–	1%	26
2017 Q4	$5.18M	Hold	405,000	–	–	0.61%	37
2017 Q3	$4.98M	Sell	405,000 -295,000	-42%	-$2.74M	0.71%	37
2017 Q2	$5.86M	Hold	700,000	–	–	1%	24
2017 Q1	$6.26M	Sell	700,000 -200,000	-22%	-$2.13M	1.22%	19
2016 Q4	$7.91M	Hold	900,000	–	–	2%	11
2016 Q3	$6.08M	Buy	+900,000	New	+$3.48M	0.99%	23
2016 Q1	–	Sell	-215,000	Closed	-$907K	–	135
2015 Q4	$907K	Sell	215,000 -135,000	-39%	-$616K	0.13%	107
2015 Q3	$1.6M	Sell	350,000 -450,000	-56%	-$2.67M	0.2%	106
2015 Q2	$5.77M	Sell	800,000 -123,922	-13%	-$914K	0.57%	34
2015 Q1	$6.81M	Sell	923,922 -50,000	-5%	-$356K	0.71%	28
2014 Q4	$4.61M	Buy	973,922 +100,000	+11%	+$396K	0.78%	37
2014 Q3	$3.12M	Buy	873,922 +588,922	+207%	+$2.32M	0.39%	63
2014 Q2	$1.3M	Buy	+285,000	New	+$1.18M	0.32%	70

Other funds holding ARRY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Sphera Funds Management's ARRY Position: Q1 2019 in Review

Sphera Funds Management sold out of Array Biopharma Inc (ARRY) in Q1 2019, closing a stake of 125,000 shares — an estimated $1.78M sold.

Sphera Funds Management first reported a position in ARRY in Q2 2014 and held it in 17 quarters. The position peaked at $7.91M in Q4 2016. 268 funds tracked by Wall St. Rank hold ARRY as of Q1 2019.

Sphera Funds Management reported no remaining Array Biopharma Inc position as of Q1 2019 after selling out during the quarter.
Sphera Funds Management sold 125,000 Array Biopharma Inc shares in Q1 2019, an estimated $1.78M.
Sphera Funds Management first reported a position in Array Biopharma Inc in Q2 2014 and held it in 17 quarters.
Sphera Funds Management's Array Biopharma Inc position peaked at $7.91M in Q4 2016.
268 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2019.

Based on Sphera Funds Management's 13F filing for Q1 2019, filed 15 May 2019.